These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6786801)

  • 61. Development of a sandwich enzyme linked immunosorbent assay (ELISA) for the quantification of iduronate-2-sulfate sulfatase.
    Sosa AC; Espejo AJ; Rodriguez EA; Lizaraso LM; Rojas A; Guevara J; Echeverri OY; Barrera LA
    J Immunol Methods; 2011 May; 368(1-2):64-70. PubMed ID: 21447345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human leucocyte cerebroside sulphate sulphatase.
    Poulos A; Beckman K
    Clin Chim Acta; 1979 Jul; 95(1):113-21. PubMed ID: 41652
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mucopolysaccharidosis II (Hunter syndrome): identification of the carrier state of the disease by means of mutation analysis].
    Balzano N; Villani GR; Coppa G; Di Natale P
    Pediatr Med Chir; 1996; 18(1):91-3. PubMed ID: 8685031
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sanfilippo D syndrome: correction of glucosamine-6-sulphatase deficiency following fibroblast culture in Chang's media.
    Freeman C; Hopwood JJ
    Prenat Diagn; 1991 Sep; 11(9):711-7. PubMed ID: 1788178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Normal excretion of urinary acid mucopolysaccharides in a boy with iduronate sulphatase deficiency, Hunter phenotype and alpha 1-antitrypsin deficiency.
    Nielsen JB; Güttler F; Hobolth N; Tønnesen T; Pedersen OD; Lykkelund C; Rosleff F
    Eur J Pediatr; 1986 Dec; 145(6):572-5. PubMed ID: 2949978
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hunter syndrome with late age of presentation: clinical description of a case and review of the literature.
    Gupta A; Uttarilli A; Dalal A; Girisha KM
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976201
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
    Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
    J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.
    Wraith JE
    Acta Paediatr; 2008 Apr; 97(457):76-8. PubMed ID: 18339193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.
    Freeman C; Hopwood JJ
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):605-14. PubMed ID: 1546976
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mutations of the iduronate-2-sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
    Schröder W; Wulff K; Wehnert M; Seidlitz G; Herrmann FH
    Hum Mutat; 1994; 4(2):128-31. PubMed ID: 7981716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biodistribution of Idursulfase Formulated for Intrathecal Use (Idursulfase-IT) in Cynomolgus Monkeys after Intrathecal Lumbar Administration.
    Chung JK; Brown E; Crooker B; Palmieri KJ; McCauley TG
    PLoS One; 2016; 11(10):e0164765. PubMed ID: 27764180
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A substrate for direct measurement of L-iduronic acid 2-sulfate sulfatase.
    Ginsberg LC; Di Ferrante DT; Di Ferrante N
    Carbohydr Res; 1978 Jul; 64():225-35. PubMed ID: 98232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. First-trimester diagnosis of Hunter syndrome (MPS II).
    Besley GT; Broadhead DM; Ellis PM
    Prenat Diagn; 1992 Jan; 12(1):72-3. PubMed ID: 1557316
    [No Abstract]   [Full Text] [Related]  

  • 75. Analysis of normal and mutant iduronate-2-sulphatase conformation.
    Parkinson-Lawrence E; Turner C; Hopwood J; Brooks D
    Biochem J; 2005 Mar; 386(Pt 2):395-400. PubMed ID: 15500445
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics and bioavailability of a therapeutic enzyme (idursulfase) in cynomolgus monkeys after intrathecal and intravenous administration.
    Xie H; Chung JK; Mascelli MA; McCauley TG
    PLoS One; 2015; 10(4):e0122453. PubMed ID: 25836678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The management of children with Hunter syndrome - a case study.
    Little C; Gould R; Hendriksz C
    Br J Nurs; 2009 Mar 12-25; 18(5):321-2. PubMed ID: 19273994
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Mucopolysaccharidosis type II (Hunter syndrome)].
    Sukegawa K; Tomatsu S; Kondo N; Orii T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):435-8. PubMed ID: 9645102
    [No Abstract]   [Full Text] [Related]  

  • 79. Human liver glucuronate 2-sulphatase. Purification, characterization and catalytic properties.
    Freeman C; Hopwood JJ
    Biochem J; 1989 Apr; 259(1):209-16. PubMed ID: 2497731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristic "pebbling" skin eruption as a presenting sign of Hunter syndrome.
    Noh TK; Han JS; Won CH; Chang S; Choi JH; Moon KC; Lee MW; Yang JH; Soung JH
    Int J Dermatol; 2014 Dec; 53(12):e594-6. PubMed ID: 25267496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.